论文部分内容阅读
Objective:The epidermal growth factor receptor(EGFR) inhibitors monoclonal antibodies(MoAbs) have already shown the therapeutic effectiveness in patients with metastatic colorectal cancer(mCRC).But many patients resist to the treatment.The aim of this met